Paid Clinical Trials in Olympia, WA
As of August 2026, 27 paid clinical trials are recruiting in Olympia, Washington. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Olympia offers studies at sites including Vista Oncology for conditions such as Breast Cancer, Carcinoma, Non-Small-Cell Lung, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Olympia
Trials by drug in Olympia
Filter results
Newly added in Olympia
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
26 clinical trials
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma
A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Adapting a Brief Suicide Intervention for Pediatric Primary Care: Enhancing Uptake and Impact
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Top Research Study Locations in Olympia
Researchers run research studies in Olympia, WA at 16 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Vista Oncology | Breast Cancer, Carcinoma, Non-Small-Cell Lung, Left-sided Colorectal Cancer | 5 |
| American Oncology Network Vista Oncology Division-East office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| American Oncology Network Vista Oncology Division-West office | Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC) | 3 |
| American Oncology Network Vista Oncology Division | Gastric Cancer, Gastroesophageal-junction Cancer, HER2-positive Gastric Cancer | 2 |
| Northwest Medical Specialties | Advanced Solid Tumors, Lymphoma, Non-Hodgkin, Metastatic Breast Cancer | 2 |
| Vista Oncology - East Olympia | Chronic Lymphocytic Leukemia, Non Small Cell Lung Carcinoma | 2 |
| American Oncology Network Vista Oncology Division / Physician partner associate | Multiple Myeloma (MM) | 1 |
| American Oncology Network Vista Oncology Division/Physician Partner Associate | Hepatocellular Carcinoma (HCC) | 1 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 1 |
| Home-based telemedicine | Chronic Granulomatous Disease (CGD) | 1 |
| Investigative | Solid Tumors | 1 |
| Olympia Pediatrics | Suicide Prevention | 1 |
| Olympia Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Providence St. Peter Hospital | Central Line Associated Blood Stream Infections (CLABSI) | 1 |
| Vista Oncology - East Olympia | Non-Small Cell Lung Cancer | 1 |
| Vista Oncology Inc PS | Non-Small Cell Lung Cancer (NSCLC) | 1 |
Active & Upcoming Studies in Olympia (2026)
Recruiting trials in Olympia grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (20 active studies)
- Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1) · Phase 3 · Genmab
- A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma · Phase 1 · Shanghai Henlius Biotech
Cardiovascular (1 active study)
Common conditions studied in Olympia
- Breast Cancer (2 active studies)
- Carcinoma, Non-Small-Cell Lung (2 active studies)
- Gastric Cancer (2 active studies)
- Gastroesophageal Junction Adenocarcinoma (2 active studies)
- Metastatic Breast Cancer (2 active studies)
- Non-Small Cell Lung Cancer (2 active studies)
Leading research sponsors in Olympia
- AbbVie
- Shanghai Henlius Biotech
- American Society of Clinical Oncology
- AstraZeneca
- Merck Sharp & Dohme LLC
Frequently asked questions
How many paid clinical trials are currently recruiting in Olympia?
There are approximately 27 recruiting clinical trials in Olympia, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Olympia pay participants?
Most recruiting trials in Olympia compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Olympia?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Olympia?
The most common conditions under active study in Olympia include Breast Cancer (2), Carcinoma, Non-Small-Cell Lung (2), Gastric Cancer (2), Gastroesophageal Junction Adenocarcinoma (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Olympia?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Olympia on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Olympia?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Olympia?
Recruiting research sites in Olympia include Vista Oncology, American Oncology Network Vista Oncology Division-East office, American Oncology Network Vista Oncology Division-West office, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Olympia right now?
The largest active categories in Olympia are Cancer & tumors (20), Cardiovascular (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.